Literature DB >> 11211612

H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.

A Sakamoto1, Y Oda, T Adachi, S Tamiya, S Matsuda, K Tanaka, Y Iwamoto, M Tsuneyoshi.   

Abstract

Point mutations of the ras gene family (K-ras, H-ras, and N-ras) are thought to be involved in the development of a variety of human tumors. Dedifferentiated liposarcoma is characterized by the coexistence of well-differentiated (WD) and high-grade anaplastic (HG) components. The presence of point mutations at codons 12 and 13 of the H-ras gene was studied in 34 liposarcomas, comprising 15 well-differentiated liposarcomas and 19 dedifferentiated liposarcomas, and in 8 storiform-pleomorphic type malignant fibrous histiocytomas (MFHs) using polymerase chain reaction-restriction fragment length polymorphism and direct sequencing analysis. The 2 components of dedifferentiated liposarcoma were analyzed independently. H-ras mutations were seen only in dedifferentiated liposarcomas (4/19 [21%]), 1 in WD components and 3 in HG components. The mutation was not seen in any of 15 cases of well-differentiated liposarcoma. MFHs showed an H-ras mutation in 1 (12%) of 8 cases. Our results seem to suggest that the H-ras mutation is a relatively uncommon event in dedifferentiated liposarcoma, which may demonstrate an epiphenomenon of dedifferentiation in dedifferentiated liposarcoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211612     DOI: 10.1309/HEF7-54YQ-JUVE-2THH

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  GISTogram: a graphic presentation of the growing GIST complexity.

Authors:  Riccardo Ricci; Angelo Paolo Dei Tos; Guido Rindi
Journal:  Virchows Arch       Date:  2013-08-23       Impact factor: 4.064

2.  Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways.

Authors:  Ralf J Rieker; Juergen Weitz; Burkhard Lehner; Gerlinde Egerer; Andrea Mueller; Bernd Kasper; Peter Schirmacher; Stefan Joos; Gunhild Mechtersheimer
Journal:  Virchows Arch       Date:  2009-12-29       Impact factor: 4.064

3.  Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma.

Authors:  Shang Guo; Hector Lopez-Marquez; Kenneth C Fan; Edwin Choy; Gregory Cote; David Harmon; G Petur Nielsen; Cao Yang; Changqing Zhang; Henry Mankin; Francis J Hornicek; Darrell R Borger; Zhenfeng Duan
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

Review 4.  Lessons from miR-143/145: the importance of cell-type localization of miRNAs.

Authors:  Oliver A Kent; Matthew N McCall; Toby C Cornish; Marc K Halushka
Journal:  Nucleic Acids Res       Date:  2014-05-29       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.